A 63-year-old man is diagnosed with advanced prostate cancer with bone metastases. According to NICE, which medication is typically added to reduce sk...

Question

A 63-year-old man is diagnosed with advanced prostate cancer with bone metastases. According to NICE, which medication is typically added to reduce skeletal-related events?

Accepted Answer

Denosumab or bisphosphonates

Answer

Tamoxifen

Answer

Calcitonin

Answer

Alpha-blocker

Answer

5-alpha reductase inhibitor

NICE Guideline NG131 on Prostate cancer MCQ (SBA): Prostate cancer with bone metastases

A 63-year-old man is diagnosed with advanced prostate cancer with bone metastases. According to NICE, which medication is typically added to reduce skeletal-related events?